There’s a New Virus-Themed ETF and It Trades Under Ticker GERM
- ETFMG Treatments, Testing and Advancements ETF starts trading
- Fund focuses on the advancements in infectious-diseases area
Photographer: Pedro Vilela/Getty Images
This article is for subscribers only.
ETF Managers Group launched an exchange-traded fund tracking companies focused on testing and treatments of infectious diseases.
The ETFMG Treatments, Testing and Advancements ETF, which started trading Thursday under the ticker GERM, gives access to both established biotechnology companies and “unsung heroes,” the firm said in a statement. The fund tracks an index whose biggest holding is Moderna Inc., a company that’s seen its stock price more than triple this year on news of its vaccine development progress.